Can SIRVA Require Surgery?
Yes. Although nonoperative treatment remains the mainstay of SIRVA management, surgery has been reported in patients with persistent symptoms that do not improve sufficiently with conservative treatment.
The more difficult questions are:
How often is surgery really needed?
What kind of surgery is performed?, and
Does needing surgery strengthen the conclusion that vaccination caused the shoulder pathology?
The literature provides useful answers, but it also contains important limitations.
Most SIRVA Treatment Starts Conservatively
Published reviews generally describe initial treatment with some combination of:
NSAIDs or other nonopioid analgesics,
activity modification,
physical or occupational therapy,
range-of-motion exercises,
and corticosteroid injection into the relevant shoulder compartment.
Wong and colleagues note that combinations of NSAIDs, subacromial or glenohumeral corticosteroid injections, and physical therapy may produce partial or complete symptom improvement. Surgery is generally discussed when symptoms remain refractory to conservative care.
This is important because SIRVA itself is not a surgical diagnosis.
The need for surgery depends on what shoulder pathology is actually present and whether that pathology remains clinically significant despite appropriate nonsurgical treatment.
The largest frequently cited surgical-treatment dataset comes from Hesse and colleagues' review of 476 SIRVA claims recommended for concession through the National Vaccine Injury Compensation Program.
Within that selected cohort: 155 patients—32.6%—underwent surgery.
Among those surgical cases, reported procedures included:
Subacromial decompression — 43.2%
Joint debridement — 31.0%
Rotator cuff repair — 29.7%
Diagnostic arthroscopy — 29.7%
Manipulation under anesthesia — 13.5%
Lysis of adhesions — 9.7%
Bursectomy — 9.0%
Synovectomy — 7.1%
as well as distal clavicle excision, labral procedures, and other operations.
This demonstrates that surgery is clearly represented in the SIRVA literature.
But the 32.6% figure should not be interpreted as the surgical rate for all patients with SIRVA.
Why the 32.6% Figure Needs Caution
The Hesse cohort consisted of people pursuing compensation through the VICP whose claims had been recommended for concession.
That population is likely enriched for:
persistent symptoms,
more severe presentations,
prolonged treatment,
and patients who remained symptomatic long enough to pursue a claim.
Therefore, the appropriate statement is:
32.6% of the 476 conceded VICP SIRVA claimants in the Hesse study had undergone surgery.
It is not:
One-third of all SIRVA patients need surgery.
That distinction is especially important in medical-legal reporting.
What Types of SIRVA Might Lead to Surgery?
The literature suggests that surgery is not directed at “SIRVA” in the abstract.
Instead, surgery is generally directed at the specific persistent pathology identified in the shoulder.
Examples include:
persistent subacromial bursitis→ bursectomy or subacromial debridement
adhesive capsulitis refractory to treatment→ manipulation under anesthesia or arthroscopic capsular release
persistent synovitis→ arthroscopic synovectomy or debridement
focal rotator cuff pathology→ debridement or repair when clinically appropriate
osseous or insertional pathology→ debridement in selected cases.
This distinction matters because the operative procedure should make sense for the identified pain generator and pathology, not simply for the history of vaccination.
Wong and colleagues reported a patient with persistent shoulder symptoms after influenza vaccination whose MRI demonstrated substantial subacromial bursitis with heterogeneous material in the bursal space.
After failed conservative treatment, the patient underwent:
arthroscopic shoulder debridement,
subacromial bursectomy,, and
biopsy/culture of abnormal material.
At surgery, the authors found extensive bursal inflammation together with multiple white, hardened, caseous-appearing bodies.
Importantly, the rotator cuff was intact and the glenohumeral joint appeared normal.
Histology demonstrated reactive changes and areas of tissue necrosis, while bacterial and fungal cultures were negative.
At three months after surgery, the patient had substantial restoration of range of motion, normal external rotation strength, and no pain with shoulder motion.
This case provides considerably more information than simply stating that surgery occurred.
It links:
persistent symptoms
→ imaging-defined pathology
→ operative confirmation of inflammation
→ pathologic evaluation
→ clinical improvement after targeted treatment.
Surgical Findings Can Sometimes Add Diagnostic Information
Surgery can occasionally provide tissue or direct visualization that imaging cannot.
Wong's case is a good example.
The arthroscopy demonstrated extensive bursal inflammation and unusual material within the subacromial space, while pathology demonstrated reactive changes and necrosis and cultures were negative.
That may strengthen the conclusion that a true local inflammatory process was present.
However:
Finding inflammation at surgery does not automatically establish why the inflammation occurred.
Bursitis and synovitis can have multiple causes.
Operative findings still need to be integrated with timing, injection anatomy, prior shoulder history, imaging, and alternative explanations.
Other Surgical Case Reports Have Shown Improvement
Wong's literature review identified earlier surgical reports in which patients underwent arthroscopic bone and soft-tissue debridement followed by postoperative physical therapy and achieved substantial functional recovery.
One particularly relevant earlier report is Hexter, Gee, and Sandher, describing management of glenohumeral synovitis secondary to influenza vaccination. Wong includes this among the prior surgical SIRVA literature.
These cases demonstrate that refractory inflammatory shoulder pathology after vaccination has, in selected patients, been treated operatively.
They do not establish the comparative effectiveness of surgery versus continued nonoperative treatment.
Acute Severe Bursitis Has Also Been Treated Arthroscopically
Mayer and colleagues reported arthroscopic debridement for acute hemorrhagic subacromial bursitis after COVID-19 vaccination.
Their review emphasized that nonoperative treatment remains the mainstay of management, but the reported patient underwent arthroscopic subacromial treatment after persistent symptoms and subsequently experienced rapid functional recovery.
Again, this is a case report. It demonstrates feasibility and a successful outcome in one clinical scenario rather than establishing a general indication for surgery.
What About Minimally Invasive Ultrasound-Guided Procedures?
Not all procedural treatment needs to involve conventional arthroscopic surgery.
Bodor, Uribe, and Srikumaran reported five highly selected patients with chronic post-vaccination shoulder dysfunction in whom ultrasound and diagnostic anesthetic injections were used to identify focal pain generators involving the posterior rotator cuff insertion and adjacent bone.
They then performed ultrasound-guided ultrasonic aspiration and debridement.
In one detailed case, QuickDASH improved from 57 before the procedure to 7 at two weeks, 5 at four weeks, and 2 at 12 weeks, while the original posterior shoulder pain remained resolved.
Their broader case-series extraction similarly showed marked early QuickDASH improvement following the procedure in a highly selected refractory population.
This represents an emerging treatment strategy rather than an established alternative to surgery.
Surgery Should Be Directed at the Pain Generator
This principle may be especially important in SIRVA. MRI often demonstrates multiple abnormalities, including degenerative rotator cuff tearing, AC arthritis, bursitis, and labral disease.
The Hesse investigators themselves cautioned that common MRI findings should not automatically be interpreted as vaccine-caused pathology.
Therefore, finding a partial-thickness rotator cuff tear after vaccination should not automatically lead to cuff surgery.
The relevant questions are:
Does the tear appear clinically significant?
Does the examination localize symptoms to it?
Is it acute or chronic appearing?
Are there associated inflammatory findings?
Did targeted nonsurgical treatment fail?
Is there another more likely pain generator?
Surgery directed at incidental pathology may not improve a patient's symptoms.
Diagnostic Injections Can Be Helpful Before Surgery
Because shoulder imaging abnormalities are common, targeted anesthetic injections can sometimes help determine which structure is actually generating pain.
This approach appears in the ultrasound-guided work by Bodor and colleagues.
For example, one patient had approximately 50% temporary relief following a targeted lidocaine injection at the abnormal infraspinatus insertion before undergoing ultrasonic debridement.
A positive diagnostic block does not prove vaccine causation.
It can, however, strengthen confidence that the proposed surgical or procedural target is actually contributing to the patient's symptoms.
Does Surgery Prove That the Original Injury Was Severe?
It proves that the treating clinicians believed the patient's condition warranted surgical management.
It does not necessarily establish the initial severity or mechanism of the injury.
A shoulder condition can become difficult to treat because of:
prolonged inflammation,
secondary adhesive capsulitis,
persistent bursitis,
preexisting pathology becoming symptomatic,
structural progression,
or failure of conservative treatment.
Thus, the clinical course should be evaluated longitudinally rather than assuming:
Surgery = severe direct needle injury.
That inference is not supported by the literature.
Does Surgery Prove Vaccine Causation?
No. This is one of the most important medical-legal distinctions.
A patient may undergo surgery after vaccination for:
vaccine-related pathology,
aggravation of preexisting disease,
coincidentally discovered degenerative disease, or
another shoulder condition entirely.
The fact that surgery occurred establishes treatment intensity.
It does not independently establish etiology.
What About Rotator Cuff Repair?
Rotator cuff repair was reported in 46 of the 155 surgical Hesse cases, representing 29.7% of the surgical subgroup.
This does not mean that vaccination was proven to have created 46 rotator cuff tears.
Hesse specifically cautioned that rotator cuff abnormalities were common in the age group studied and could exist independently of vaccination.
A rotator cuff repair performed after a suspected SIRVA event therefore needs the same careful analysis discussed in our imaging posts:
Was the tear new, preexisting, incidental, aggravated, or actually responsible for the patient's post-vaccination symptoms?
The surgical history alone cannot answer that question.
What About Adhesive Capsulitis?
A patient with post-vaccination adhesive capsulitis may occasionally progress to more invasive treatment if symptoms remain refractory.
In the Hesse surgical subgroup:
21 patients underwent manipulation under anesthesia, and
15 underwent lysis of adhesions.
These procedures are familiar treatments for refractory adhesive capsulitis independent of vaccination.
That reinforces a broader treatment principle:
Once the specific pathology has been identified, treatment generally follows established shoulder-care principles for that pathology.
The disputed issue in many SIRVA cases is not whether the procedure is a recognized treatment, but what caused the pathology that ultimately required it.
When Might Surgery Be Reasonable?
The available literature suggests that surgery may be considered when several features align:
persistent clinically significant symptoms
a defined structural or inflammatory pain generator
failure of appropriate conservative management
objective clinical or imaging correlation
a reasonable expectation that treating the identified pathology will improve function or pain.
That framework is consistent with ordinary orthopedic decision-making.
There is no established evidence-based rule that a patient should undergo surgery after a particular number of weeks or months simply because the diagnosis is SIRVA.
The Literature Does Not Tell Us the Best Time for Surgery
This remains a major evidence gap. There are no randomized trials comparing:
early surgery vs delayed surgery, or
surgery vs continued conservative treatment
for SIRVA.
Most evidence comes from:
case reports,
small series,
retrospective claims data,
and narrative or systematic reviews.
Therefore, surgical decisions remain individualized.
What Does a Good Surgical Causation Analysis Require?
When surgery becomes part of a SIRVA case, the operative records can provide valuable additional evidence. Useful questions include:
What exactly was found at surgery?
Did the operative findings match the preoperative MRI or ultrasound?
Was inflammation present?
Was the rotator cuff intact or torn?
Were cultures or pathology obtained?
Were degenerative changes documented?
What procedure was actually performed?
Did treatment of the identified structure improve the patient's original symptoms?
These details are often much more informative than simply stating that a patient “required shoulder surgery.”
The Bottom Line
Can SIRVA require surgery?
Yes, but surgery is the exception rather than the defining feature of SIRVA.
The literature clearly documents surgical treatment in selected patients with persistent post-vaccination shoulder dysfunction.
The Hesse VICP claims study found surgery in 32.6% of its highly selected conceded claimant population, with procedures ranging from subacromial decompression and debridement to rotator cuff repair, capsular procedures, bursectomy, and synovectomy.
Case reports such as Wong demonstrate that arthroscopic debridement and bursectomy can produce substantial improvement in carefully selected patients with persistent, objectively demonstrated inflammatory pathology.
But three distinctions are essential:
Surgery after vaccination does not automatically prove SIRVA.
Surgery for a rotator cuff tear does not automatically prove that vaccination caused the tear.
And the 32.6% surgical rate from a compensation-selected population should not be extrapolated to all patients with SIRVA.
The most defensible interpretation is that surgery represents one possible treatment for selected refractory pathology within the broader SIRVA spectrum, and its relevance to causation must be determined from the complete clinical record.
References
Hesse EM, Atanasoff S, Hibbs BF, et al. Shoulder Injury Related to Vaccine Administration (SIRVA): petitioner claims to the National Vaccine Injury Compensation Program, 2010-2016. Vaccine. 2020;38(5):1076-1083.
Wong W, Barnes LA, Williams D, et al. Arthroscopic surgical management of shoulder secondary to shoulder injury related to vaccine administration (SIRVA): a case report. J Shoulder Elbow Surg. 2021;30:e334-e337.
Hexter AT, Gee E, Sandher D. Management of glenohumeral synovitis secondary to influenza vaccination. Shoulder Elbow. 2015;7(2):100-103.
Mayer A, et al. Arthroscopic debridement for acute hemorrhagic subacromial bursitis following COVID-19 vaccine administration: a case report. Shoulder Elbow. 2023 Oct;15(5):527-533.
Bodor M, Uribe Y, Srikumaran U. Ultrasonic aspiration for vaccination-related shoulder dysfunction. Heliyon. 2021;7:e08442.
Atanasoff S, Ryan T, Lightfoot R, Johann-Liang R. Shoulder injury related to vaccine administration (SIRVA). Vaccine. 2010;28(51):8049-8052.
Macomb CV, Evans MO, Dockstader JE, Montgomery JR, Beakes DE. Treating SIRVA early with corticosteroid injections: a case series. Mil Med. 2020;185:e298-e300.
Wiesel BB, Keeling LE. Shoulder injury related to vaccine administration. J Am Acad Orthop Surg. 2021;29(17):732-739.
Pettyjohn EW, Clugston JR, Zaremski JL. Shoulder injury related to vaccine administration and a growing challenge: a focused review. Curr Sports Med Rep. 2022;21(3):78-83.
MacMahon A, Nayar SK, Srikumaran U. What do we know about shoulder injury related to vaccine administration? An updated systematic review. Clin Orthop Relat Res. 2022;480(7):1241-1250.
Slette E, Rohrback M, Ring D. Persistent shoulder pain after vaccine administration is associated with common incidental pathology: a systematic review. Clin Orthop Relat Res. 2022;480(7):1251-1258.
Salmon JH, Geoffroy M, Eschard JP, Ohl X. Bone erosion and subacromial bursitis caused by diphtheria-tetanus-poliomyelitis vaccine. Vaccine. 2015;33:6152-6155.
Comments